4.7 Article

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Rheumatology

Interleukin 6: from bench to bedside

Norihiro Nishimoto et al.

NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)